quinoxalines has been researched along with n(6)-cyclopentyladenosine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Browne, RG; Howard, HR; Koe, BK; Lebel, LA; Sarges, R; Seymour, PA | 1 |
| Huguenard, JR; Ulrich, D | 1 |
| Bertaccini, G; Poli, E; Pozzoli, C | 1 |
| Cox, SL; Gaiser, EG; Meyer, A; Starke, K; Trendelenburg, AU | 1 |
| Assaloni, R; Bartoli, E; Cavarape, A; Endlich, K; Endlich, N; Parekh, N; Steinhausen, M | 1 |
| Fragata, IR; Ribeiro, JA; Sebastião, AM | 1 |
6 other study(ies) available for quinoxalines and n(6)-cyclopentyladenosine
| Article | Year |
|---|---|
4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Antidepressive Agents; Behavior, Animal; Caffeine; Cats; Cell Membrane; Cerebral Cortex; Chemical Phenomena; Chemistry; Corpus Striatum; Male; Molecular Structure; Motor Activity; Purinergic Antagonists; Quinoxalines; Rats; Receptors, Purinergic; Sleep; Structure-Activity Relationship; Triazoles | 1990 |
Purinergic inhibition of GABA and glutamate release in the thalamus: implications for thalamic network activity.
Topics: Adenosine; Animals; Bicuculline; Electric Conductivity; Excitatory Amino Acid Antagonists; Female; GABA Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Male; Quinoxalines; Rats; Receptors, Purinergic P1; Synapses; Thalamus; Theophylline | 1995 |
Interaction between histamine H3 receptors and other prejunctional receptor systems in the isolated guinea pig duodenum.
Topics: Acetylcholine; Adenosine; Animals; Brimonidine Tartrate; Duodenum; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Male; Methylhistamines; Muscle Contraction; Quinoxalines; Receptors, Adrenergic, alpha-2; Receptors, Histamine H3; Receptors, Purinergic P1 | 1997 |
Noradrenaline release from cultured mouse postganglionic sympathetic neurons: autoreceptor-mediated modulation.
Topics: Adenosine; Adenosine Triphosphate; Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Cells, Cultured; Electric Stimulation; Ganglia, Sympathetic; Humans; Idazoxan; Kinetics; Mice; Mice, Inbred Strains; Neurons; Norepinephrine; Phenethylamines; Phentolamine; Purinergic P1 Receptor Agonists; Quinoxalines; Receptors, Adrenergic, alpha-2; Tritium; Yohimbine | 1999 |
Rho-kinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo.
Topics: Adenosine; Amides; Animals; Endothelins; Enzyme Inhibitors; Female; Guanylate Cyclase; Indoles; Intracellular Signaling Peptides and Proteins; Oxadiazoles; Peptide Fragments; Protein Kinase C; Protein Serine-Threonine Kinases; Purinergic P1 Receptor Agonists; Pyridines; Quinoxalines; Rats; Rats, Wistar; Receptor, Endothelin B; Receptors, Endothelin; Renal Circulation; rho-Associated Kinases; Signal Transduction; Vasoconstriction; Vasomotor System | 2003 |
Nitric oxide mediates interactions between GABAA receptors and adenosine A1 receptors in the rat hippocampus.
Topics: 2-Chloroadenosine; Adenosine; Animals; Bicuculline; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; GABA Antagonists; gamma-Aminobutyric Acid; Guanylate Cyclase; Hippocampus; In Vitro Techniques; Male; Neural Inhibition; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroarginine; Oxadiazoles; Penicillamine; Quinoxalines; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptors, GABA-A; Synaptic Transmission | 2006 |